Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • GlaxoSmithKline...

    GlaxoSmithKline Consumer Healthcare Ltd Q4 net profit up 8 per cent at Rs 175 cr

    Written by Ruby Khatun Khatun Published On 2017-05-16T12:07:11+05:30  |  Updated On 16 May 2017 12:07 PM IST
    GlaxoSmithKline Consumer Healthcare Ltd Q4 net profit up 8 per cent at Rs 175 cr

    New Delhi: GlaxoSmithKline Consumer Healthcare Ltd reported a 8.42 per cent increase in standalone net profit at Rs 175.88 crore for the fourth quarter ended March 31.


    The company had posted a net profit of Rs 162.22 crore for the corresponding period a year ago, GSK Consumer Healthcare said in a BSE filing.


    Total income from operations for the quarter under review stood at Rs 1,208.76 crore as against Rs 1,192.22 crore during the same period last fiscal, up 13.87 per cent.



    GSK Consumer Healthcare Managing Director Manoj Kumar said: "The fourth quarter has delivered positive results for the company. We continue to remain the market leader in health food drinks category."

    For the entire fiscal, the company however reported a decline in net profit at Rs 656.67 crore as against Rs 687.28 crore in 2015-16 fiscal.


    Total income from operations for the financial year stood at Rs 4,421.09 crore compared to Rs 4,564.38 crore in the previous year.


    GSK said that its board has recommended a dividend of Rs 70 per equity share of Rs 10 each for the 12-month period ended March 31, 2017.


    Shares of the company closed 1.93 per cent down at Rs 5,250.80 apiece on BSE.

    208.76 crore8.42 per cent increaseGlaxoSmithKlineGlaxoSmithKline Consumer Healthcare LtdGSKManoj Kumarnet profitRs 1Rs 175.88 croreTotal income
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok